University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant

UMEM Educational Pearls

  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls
Previous  |  1 |  ... |  81 |  82 |  83 |  84 |  85 |  86 |  87 |  88 |  89 |  90 |  91 |  ... |  239 |  Next

Title: Pediatric Acute Respiratory Distress Syndrome (ARDS)

Category: Pediatrics

Keywords: ARDS, oxygenation index, OI, PALICC, acute lung injury (PubMed Search)

Posted: 9/22/2017 by Mimi Lu, MD (Updated: 10/27/2017)

Since the first description of acute respiratory distress syndrome (ARDS), various consensus conferences (including American-European Consensus Conference (AECC) and the Berlin Conference) have produced definitions focused on adult lung injury but have limitations when applied to children. 

This prompted the organization of the Pediatric Acute Lung Injury Consensus Conference (PALICC), comprised of  27 experts, representing 21 academic institutions and eight countries.  The goals of the conference were 1) to define pediatric ARDS (PARDS); 2) to offer recommendations regarding therapeutic support; and 3) to identify priorities for future research in PARDS.

Although there were several recommendations from the group, some notable ones, in contrast to the Berlin definition focused on adults, include: 1) use the Oxygenation Index (or, if an arterial blood gas is not available, the Oxygenation Severity Index) rather than the P/F ratio; 2) elimination of the requirement for “bilateral” pulmonary infiltrates (may be unilateral or bilateral) 3) elimination of  specific age criteria for PARDS.

Tune in next month for pearls on management for children with PARDS...

Show References

Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations from the Pediatric Acute Lung Injury Consensus Conference.  Pediatric Acute Lung Injury Consensus Conference Group. Pediatr Crit Care Med. 2015 Jun;16(5):428-39

Collaborators: Jouvet P, Thomas NJ, Wilson DF, Erickson S, Khemani R, Zimmerman J, Dahmer M, Flori H, Quasney M, Sapru A, Cheifetz IM, Rimensberger PC, Kneyber M, Tamburro RF, Curley MA, Nadkarni V, Valentine S, Emeriaud G, Newth C, Carroll CL, Essouri S, Dalton H, Macrae D, Lopez-Cruces Y, Quasney M, Santschi M, Watson RS, Bembea M.



Title: Drug Induced Hyperkalemia

Category: Toxicology

Keywords: Hyperkalemia (PubMed Search)

Posted: 9/22/2017 by Kathy Prybys, DO (Updated: 10/5/2017)

Hyperkalemia is a potentially life threatening problem which can lead to cardiac dysrhythmias and death.  Drug interactions inducing hyperkalemia are extremely common such as the combination of ACE inhibitors and spironolactone or ACE inhibitors and trimehoprim sulfamethoxazole. Hyperkalemia can also occur with a  single agent and is a relatively common complication of therapy with trimethoprim sulfamethoxazole. The following drugs can cause hyperkalemia:

  • Ace inhibitors
  • Beta blockers
  • Cyclosporine
  • Digitalis
  • Non-steroidal Anti-inflammatory Drugs
  • Pentamidine
  • Potassium supplement
  • Succinylcholine
  • Tacrolimus
  • Trimethoprim sulfamethoxazole 

 

Show References

Drug induced hyperkalemia. Salem B. Badreddine A, et al. Drug Safety 2014 Sept;37(9) 677-92.

Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Weir MA, Juurlink DN, et al. Clin J Am Soc Nephrol. 2010;5:1544-1551.



Title: One of the most venomous marine animals

Category: International EM

Keywords: Octopus, tetrodotoxin (PubMed Search)

Posted: 9/20/2017 by Jon Mark Hirshon, MPH, MD, PhD

The blue-ringed octopus (genus Hapalochlaena) is normally found in the Great Barrier Reef and other coastal waters and tide pools around Australia and other Western Pacific islands. Though not an aggressive animal, when it does bite, such as stepped upon, it can inject tetrodotoxin along with a number of other toxic compounds.

 

Tetrodotoxin can cause paralysis, leading to respiratory failure and death, though the blockage of voltage-gated fast sodium channel conduction, blocking peripheral nerve conduction. Treatment is supportive, as the venom usually wears off within 4 to 10 hours.

Show References

http://emedicine.medscape.com/article/771002-treatment#d10



Title: Post-Arrest Mechanical Ventilation

Category: Critical Care

Posted: 9/19/2017 by Mike Winters, MBA, MD (Updated: 9/18/2026)

Post-Arrest Tidal Volume Setting

  • Most patients with ROSC from out-of-hospital cardiac arrest undergo endotracheal intubation and mechanical ventilation.
  • Optimal management of mechanical ventilation for the post-arrest patient is currently not well defined.
  • A recent retrospective cohort study sought to determine if a lower tidal volume (Vt) was associated with improved neurocognitive outcome at hospital discharge.
  • Of 256 patients included in the study, investigators found:
    • 38% were ventilated with Vt > 8 ml/kg predicted body weight
    • Lower Vt was significantly associated with favorable neurocognitive outcome, decreased duration of mechanical ventilation, and decreased ICU length of stay
  • Take Home Pearl: Pay attention to Vt in the post-arrest patient.

Show References

Beitler JR, et al. Favorable neurocognitive outcome with low tidal volume ventilation after cardiac arrest. Am J Respir Crit Care Med. 2017; 195:1196-1206.



Title: Adverse outcomes during procedural sedation associated with upper respiratory tract infections

Category: Pediatrics

Keywords: Sedation, URI, adverse events (PubMed Search)

Posted: 9/15/2017 by Jenny Guyther, MD (Updated: 9/18/2026)

Elective surgeries with general anesthesia are often cancelled when the child has an upper respiratory tract infection.  What are the adverse events when procedural sedation is used when the child has an upper respiratory tract infection?

Recent and current URIs were associated with an increased frequency of airway adverse events (AAE).  The frequency of AAEs increased from recent URIs, to current URIs with thin secretions to current URIs with thick secretions.   Adverse events not related to the airway were less likely to have a statistically significant difference between the URI and non-URI groups

AAEs for children with no URI was 6.3%.  Children with URI with thick/green secretions had AAEs in 22.2% of cases.  Children with URIs did NOT have a significant increase in the risk of apnea or need for emergent airway intervention.  The rates of AAEs, however, still remains low regardless of URI status.

 

 

Show Additional Information

Data was collected on over 83,000 patients retrospectively from a voluntary database, The Pediatric Sedation Research Consortium.  Children with URIs (no fever) who underwent procedural sedation for things such as imaging or hematology/oncology procedures were included.  Propofol, dexmedetomidine, ketamine and opiates were the most commonly used agents.

AAEs included wheezing, secretions requiring treatment, cough, stridor, desaturations, obstruction, snoring, laryngospasm, and apnea.

 

Show References

Mallory et al.  Upper Respiratory Infections and Airway Adverse Events in Pediatric Procedural Sedation.  Pediatrics. 2017; 140 (1): 1-10.



Title: Can sodium glucose-cotransporter 2 (SGLT2) inhibitors cause hypoglycemia?

Category: Toxicology

Keywords: SGLT2 inhibitors, diabetes (PubMed Search)

Posted: 9/14/2017 by Hong Kim, MD

During the past several years, several new classes of diabetic medications were introduced for clinical use, including SGLT2 inhibitors (canagliflozin, dapagliflozin and empagliflozin).

SGLT2 inhibitors prevent reabsorption of glucose in the proximal convoluted tubules in the kidney and does not alter insulin release.

A recent retrospective study (n=88) of 13 poison center data from January 2013 to December 2016 showed

  1. 91% of the patients were asymptomatic.  
  2. 7% developed minor symptoms (tachycardia, nausea/vomiting, abdominal pain, & confusion)
  3. 2% developed moderate symptoms (metabolic acidosis, hypertension [166/101], & hypokalemia)
  4. Hypoglycemia was not reported.

49 patients were evaluated in a health care facility (HCF) with 18 admissions. Referral to HCF was more common in pediatric patients. This was likely due to unfamiliarity with a new mediation and lack of toxicity data.

Other case reports have shown higher incidence of DKA with the therapeutic use of SGLT2 vs. other classes of DM medications.

 

Bottom line:

Limit data is available regarding the toxicologic profile of SGLT2 inhibitors.

Based upon this small retrospective study, hypoglycemia may not occur and majority of the patient experience minimal symptoms.

Show References

Schaeffer SE et al. Retrospective review of SGLT2 inhibitor exposures reported to 13 poison center. Clin Toxicol (Phila).2017 Aug 16:1-5 PMID: 28812381

Burke KR et al. SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacothearpy. 2017;37:187-194



Title: IV vs. Non-IV Benzodiazepines for Cessation of Seizures

Category: Neurology

Keywords: seizure, status epilepticus, benzodiazepine, RAMPART, pediatric (PubMed Search)

Posted: 9/13/2017 by WanTsu Wendy Chang, MD (Updated: 9/14/2017)

IV vs. Non-IV Benzodiazepines for Cessation of Seizures

  • A meta-analysis by Alshehri et al. included 11 studies with a total of 1633 patients, comparing IV vs. non-IV benzodiazepines from any route (buccal, intranasal, intramuscular) for seizure cessation in status epilepticus.
  • They found that non-IV benzodiazepine is more effective than IV benzodiazepine in patients presenting without IV access.
  • The largest and highest quality study included in the meta-analysis was the RAMPART study, which was also the only study to include adults.
  • When considering pediatric studies only, there is no difference between IV vs. non-IV benzodiazepine in seizure cessation for status epilepticus.

Show Additional Information

  • Benzodiazepine is first-line therapy for treatment of status epilepticus.
  • The RAMPART study in 2012 by Silbergleit et al. demonstrated that prehospital treatment of status epilepticus with IM midazolam was more effective than IV lorazepam, even though the time from drug administration to seizure cessation was shorter for IV lorazepam.
  • It is important to note that there is a 30% treatment failure rate for a single appropriately dosed benzodiazepine in treatment of status epilepticus.

Show References

  • Alshehri A, Abulaban A, Bokhari R, et al. Intravenous vs. nonintravenous benzodiazepines for the cessation of seizures: a systematic review and meta-analysis of randomized controlled trials. Acad Emerg Med 2017;24(7):875-83.
  • Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600.

Follow me on Twitter @ EM_NCC



Title: Negative-Pressure Pulmonary Edema

Category: Critical Care

Keywords: respiratory failure, pulmonary edema, airway obstruction (PubMed Search)

Posted: 9/12/2017 by Kami Windsor, MD

Negative-pressure pulmonary edema (NPPE) is a well-documented entity that occurs after a patient makes strong inspiratory effort against a blocked airway. The negative pressure causes hydrostatic edema that can be life-threatening if not recognized, but if treated quickly and appropriately, usually resolves after 24-48 hours. These patients may have any type of airway obstruction, whether due to edema secondary to infection or allergy, laryngospasm, or traumatic disruption of the airway, such as in attempted hangings.

Management: 

1.     Alleviate or bypass the airway obstruction.

·      Usually via intubation; may require a surgical airway

·      If obstruction in an intubated patient is due to biting on tube or dyssynchrony, add bite-block (if not already in place), sedation, and even paralysis if needed.

2.     Provide positive pressure ventilation and oxygen supplementation.

3.     Use low tidal volume ventilation.

4.     In severe hypoxemia without shock, add a diuretic agent and consider additional measures such as proning and even ECMO if the hypoxemia is refractory to standard therapy.  

Show Additional Information

Negative-pressure pulmonary edema (NPPE), also called post-obstructive pulmonary edema, can occur after any event in which a patient exerts strong inspiratory effort against an obstructed airway. This obstruction can be essentially due to any cause; in adults it is most well-documented secondary to post-extubation laryngospasm, in children the etiology is usually infectious, such as in epiglottitis. It has also been documented secondary to laryngeal edema, tumor, trauma, biting on an endotracheal tube, vent dyssynchrony,  as well as disruptions to breathing mechanics during generalized seizures, among other causes.

It is noted that many of the documented cases involve patients who are relatively young and otherwise healthy, and thus capable of creating a strong negative intrathoracic pressure. The pathophysiology is thought to be related to hydrostatic mechanisms rather than a “leaky-capillary” permeability edema, and it usually resolves quickly if managed appropriately, within 24-48 hours. Diffuse alveolar hemorrhage, related to capillary rupture from the negative pressure, has been documented to occur in severe cases but is rare.

Consider the diagnosis in patients with an appropriate clinical picture or witnessed event leading to abrupt respiratory distress and/or failure. The diagnosis is even more strongly supported if they had absence of respiratory symptoms, or a clear chest x-ray prior to the event, with a chest x-ray demonstrating pulmonary edema afterwards.

Appropriate management of these patients includes:  

1.     Alleviation or bypass of the upper airway obstruction, which usually requires intubation.

·      Depending on the etiology of obstruction (e.g. epiglottitis), endo/nasotracheal intubation may be difficult and a surgical airway may be necessary. Be prepared for this possibility.

·      Ventilated patients who develop NPPE may require sedation to prevent biting on the ETT or to promote vent synchrony

2.     Provide with positive-pressure ventilation to counteract the negative airway pressures, and oxygen supplementation to decrease pulmonary vascular resistance.

3.     Lung-protective ventilation with low tidal volumes is generally accepted as the preferred ventilation strategy in these patients, extrapolated from data regarding its use in acute lung injury.

4.     In cases of moderate to severe hypoxemia without the presence of shock, add a diuretic agent.

5.     For refractory hypoxemia, consider early utilization of additional therapies, including neuromuscular blockade, proning, and ECMO. 

Show References

Bhattacharya M, Kallet RJ, Ware LB, Matthay MA. Negative-pressure pulmonary edema. Chest. 2016;150(4):927-33. 

Contou D, Voiriot G, Djibre et al. Clinical features of patients with diffuse alveolar hemorrhage due to negative-pressure pulmonary edema. Lung. 2017;195(4):477-487. 



Title: Viscosupplementation

Category: Orthopedics

Keywords: Knee OA, injection (PubMed Search)

Posted: 9/9/2017 by Brian Corwell, MD (Updated: 9/18/2026)

 

Viscosupplementation

Hyaluronic acid (HA) is a high-molecular weight polysaccharide

A major component of synovial fluid and of cartilage

Major role of HA is as a lubricant, shock absorption, antinociceptive effect

               Used in veterinary medicine for decades

Multiple brands exist with differences based on the molecular weight and how they are produced

Use supported by the Cochrane database (2007, 2014) for knee OA

Post injection strength gains are due to pain relief

May have a role for those who cannot receive steroid injections

Inject in similar manner to intra articular steroids

Caution in those with known allergy to poultry /eggs

Risks: Local reaction (likely from preservative), injection site pain, infection, bleeding.



Title: X-rays in poisoning diagnosis?

Category: Toxicology

Keywords: Radiographs, poisoning (PubMed Search)

Posted: 9/8/2017 by Kathy Prybys, DO (Updated: 9/8/2017)

Radiographs studies can be valuable in poisoning diagnosis, management, and prognosis.  Radiographic imaging should be utilized for the following toxins:

Heavy metals 
  • Iron (gastrointestinal)
  • Mercury (gastrointestinal, intravenous or subcutaneous)
  • Lead (bullets intraarticular, gastrointestinal foreign bodies, lead lines)
  • Zinc phosphide (gastrointestinal)

Container toxins - Body packers

  • Drug packets and vials

Sustained Released preparations

  • Potassium Chloride
Button Batteries and Coins

Show Additional Information

Image result for body packer

Show References

Plain adominal radiography: a powerful tool to prognosticate outcome in patients with zinc phosphide.  Hassanian-Moghaddam H, Shahnazi M, et al. Clin Radiolol. 2014. Oct;69 (10);1062-5.

Systemic Plumbism following remote ballistic injury, Reinboldt M, Franics K, Emerg Radio. 2014 Aug:21 (4): 423-6.

Lead arthropathy: radiographic, CT, and MRI findings, Fernandes JL, Rocha AA, et al. Skeletal Radiol. 2007 Jul;36(7):647-57.

Intentional Intravenous Mercury injection. Yudelowitz G. S Afr Med J. 2017 Jan 30;107(2):112-114.

The role of radiology in diagnosis and management of drug mules: an update with new challenges and new diagnostic tools. Schulz B. Grossbach A, et al. Clin Radiol. 2014 Dec;69(12)

Sustained-release potassium chloride overdose. J Toxicol Clin Toxicol. Su M. Stork C, et al.2001;39(6):641-8.
 

 
 

 



Title: ACMT and AACT position statement on preventing fentanyl analog exposure in emergency responders.

Category: Toxicology

Keywords: fentanyl, first responder exposure (PubMed Search)

Posted: 9/7/2017 by Hong Kim, MD

There have been reports of “intoxication” or adverse effects among first responders and law enforcement due to exposure to a “powder” suspected to be fentanyl or its analog.

 

This has led to a significant concern among first responders and law enforcement when investigating or handling “powder” at the scene of overdose or drug enforcement related raids. (http://www.foxnews.com/health/2017/08/15/police-department-gets-hazmat-like-protective-gear-for-overdose-calls.html)

 

American College of Medical Toxicology and American Association of Clinical Toxicology recently published a position statement to help clarify the potential health risk associated with exposure to fentanyl and its analogs.

 

  1. Opioid toxicity is unlikely from incidental dermal exposure.
  2. Nitrile gloves provide sufficient protection against dermal exposure.
  3. N95 respirator provide sufficient protection against aerosolize fentanyl/opioids.
  4. Naloxone should be administered for patients with objective signs of opioid toxicity - hypoventilation and CNS depression – not for vague or subjective symptoms.


Title: Top Natural Disasters By Death Toll

Category: International EM

Keywords: Floods, earthquakes, hurricanes, natural disasters (PubMed Search)

Posted: 9/6/2017 by Jon Mark Hirshon, MPH, MD, PhD (Updated: 9/18/2026)

With the recent destruction by Hurricane Harvey and the impending impact of Hurricane Irma, it is important to recognize the historical death toll from natural disasters. While the list can vary, here is a top ten list from the library of the National Oceanic and Atmospheric Administration:

Rank

Event

Location

Date

Death Toll (Estimate)

1

1931 Yellow River flood

Yellow River, China

Summer 1931

850,000-4,000,000

2

1887 Yellow River flood

Yellow River, China

September-October 1887

900,000-2,000,000

3

1970 Bhola cyclone

Ganges Delta, East Pakistan

November 13, 1970

500,000- 1,000,000

4

1201 Earthquake

Eastern Mediterranean

1201

1,000,000

5

1938 Yellow River flood

Yellow River, China

June 9th, 1938

500,000 - 900,000

6

Shaanxi Earthquake

Shaanxi Province, China

January 23, 1556

830,000

7

2004 Indian Ocean earthquake/tsunami

Indian Ocean

December 26, 2004

225,000-275,000

8

1881 Haiphong Cyclone

Haiphong, Vietnam

1881

300,000

9

1642 Kaifeng Flood

Kaifeng, Henan Province, China

1642

300,000

10

Tangshan Earthquake

Tangshan, China

July 28, 1976

242,000*

* Official Government figure. Estimated death toll as high as 655,000.

 

 

Show References

https://docs.lib.noaa.gov/noaa_documents/NOAA_related_docs/death_toll_natural_disasters.pdf



Title: Falls in the Elderly (Submitted by Amal Mattu, MD)

Category: Geriatrics

Keywords: arrhythmia, syncope, fall (PubMed Search)

Posted: 9/4/2017 by Danya Khoujah, MBBS (Updated: 9/18/2026)

20% of unexplained falls in the elderly can be attributed to an arrhythmia.

Show References

Bhangu J, McMahon CG, Hall P, et al. Long-term cardiac monitoring in older adults with unexplained falls and syncope. Heart 2016;102:681-686.



Title: Alpha-Blockers for the Management of Ureteral Stones

Category: Pharmacology & Therapeutics

Keywords: Ureteral stones, Alpha-blockers (PubMed Search)

Posted: 9/2/2017 by Wesley Oliver (Updated: 9/18/2026)

Alpha-blockers (tamsulosin, alfuzosin, doxazosin, and terazosin) are antagonists of alpha1A-adrenoreceptors, which results in the relaxation of ureteral smooth muscle.    Current evidence suggests alpha-blockers may be useful when ureteral stones are 5-10 mm; however, there is no evidence to support the use of alpha-blockers with stones <5 mm.  Patients with ureteral stones >10 mm were excluded from studies utilizing these medications.

The size of most ureteral stones will be unknown due to the lack of need for imaging able to measure stone size. Given that the median ureteral stone size is <5 mm, most patients will not benefit from the use of an alpha-blocker.

Also, keep in mind that the data for adverse events with alpha-blockers used for ureteral stones is limited and that these medications have a risk of hypotension.

 

Show Additional Information

Ferre RM et al. Tamsulosin for ureteral stones in the emergency department: a randomized, controlled trial. Ann Emerg Med 2009.

  • 77 patients

  • Ibuprofen + oxycodone + tamsulosin vs. ibuprofen + oxycodone

  • Stone expulsion at 14 days: Tamsulosin group=77.1% vs. Standard therapy=64.9%

-Difference=12% (95% CI: -8.4-32.8%)

  • No clinically/statistically significant differences

 

Pickard R et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 2015.

  • 1,136 patients

  • Tamsulosin vs. nifedipine vs. placebo

  • No further intervention at 4 weeks: Tamsulosin=81% vs. Nifedipine=80% vs. Placebo=80%

  • No clinically/statistically significant differences

 

Furyk JS et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med 2016.

  • 403 patients

  • Tamsulosin vs. placebo

  • Stone passage at 28 days: Tamsulosin=87% vs. Placebo=81.9%

-Difference=5% (95% CI: -3-13%)

  • Found difference in subgroup analysis of large stones (5-10 mm)

-Tamsulosin=83.3% vs. Placebo=61%

-Difference=22.4% (95% CI: 3.1-41.6%)

  • No other clinically/statistically significant differences

 

Hollingsworth JM et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ 2016.

  • Meta-analysis of 55 trials

  • No benefit in patients with smaller stones (<5 mm): RR=1.19 (95% CI: 1.00-1.98)

  • Benefit in patients with larger stones (5-10 mm): RR=1.57 (95% CI: 1.39-1.61)

Show References

1.) Ferre RM, Wasielewski JN, Strout TD, Perron AD. Tamsulosin for ureteral stones in the emergency department: a randomized, controlled trial. Ann Emerg Med 2009;54:432-9.

2.) Furyk JS, Chu K, Banks C, et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med 2016;67:86-95.

3.) Hollingsworth JM, Canales BK, Rogers MAM, et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ 2016;355:i6112.

4.) Pickard R, Starr K, MacLennan G, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 2015;386:341-9.

 


Title: VTE in Pediatrics

Category: Pediatrics

Keywords: VTE, Thrombophilia, Enoxaparin, Children, Thromboembolism (PubMed Search)

Posted: 9/1/2017 by Megan Cobb, MD

Background:

There is an increased incidence of venous thromboembolic events (VTE) in pediatrics due to improved diagnosis and survival of children with VTE.

The mortality rate is estimated at 2%.

The most common etiologies vary by age - Central venous catheters in neonates and infants, and inherited thrombophilia in children and adolescents.

Learning Points:

  1. With neonates and infants, carefully assess medical history from neonatal period. Umbilical lines? PICC? Broviac? History of these is likely to be the cause.

  2. In children and adolescents, unprovoked VTE is most likely due to inherited thrombophilia, and can be DVT, PE, Portal venous thrombus, etc.

    1. Antithrombin deficiency: The first discovered inherited thrombophilia. The result is a lack of inhibition of coagulation factors – IIa, IXa, Xa, XIIa.

    2. Protein C or/and S deficiency: The result is lack of inhibition of activated Factor V.

    3. Factor V Leiden: Most common inherited thrombophilic defect. Resultant activated Factor V is resistant to normal Protein C and S activity.

    4. Prothrombin Mutation: Second most common inherited thrombophilia. The result is increased levels of prothrombin, which increases the half-life of factor Va.

  3. Initial treatment of clinically significant VTE can start with enoxaparin (1-1.5 mg/kg q12-24h, while checking Anti-Xa levels 4 hours after administration for therapeutic dosing.)

 

Pearl: Testing for thrombophilia is not always appropriate when diagnosing pediatric patients with their first VTE, but in children and adolescents with first diagnosed, unprovoked VTE, it is worthwhile to send off the initial hypercoaguability work up as this can affect the duration of treatment and need for testing or evaluation. Enoxaparin is a recommended medication to start therapeutic treatment of VTE, even in pediatric patients.

Show References

Van Ommen CH, Nowak-Gottl U. Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Treat. Frontiers in Pediatrics. 2017: 5(20).

The Harriet Lane Handbook, 20th edition. Chapter 29: Drug Dosages. 2015



Title: Deadly in a drop!

Category: Toxicology

Keywords: Botulinum, Dimethylmercury, VX, Tetrodotoxin (PubMed Search)

Posted: 8/31/2017 by Kathy Prybys, DO (Updated: 8/31/2017)

Botulinum
  • Most poisonous substance known to man
  • LD50 oral dose 1 mcg/kg
  • Heat labile single polypeptide chain undergoes proteolytic clevage irreverisibly binds  and blocks cholinergic transmission causing a deadly neuroparalytic syndrome
  • Rx: Botulin antitoxin (equine derived against Clostriduim botulinum A,B,E)
Dimethylmercury (CH3)2 Hg
  • Highly toxic, restricted availability is rapidly absorbed and metabolized to methylmercury crosses CNS
  • LD50 of 50 mcg/kg means a dose as little as 0.1ml can result in severe poisoning
  • Death of Darmouth inorganic chemist Karen Wetterhahn who spilled a few drops on back of her latex gloved hand, quickly permeated, and absorbed causing severe neurotoxocity and death 10 months later
  • Rx: Chelation

VX ("venomous agent X") 

  • Organophosphate nerve agent has been used as chemical weapon
  • Colorless, odorless, low volatility, and high lipophilicity
  • LD50 of 0.04mg/kg (10 mg). Death can occur within 15 minutes after absorption
  • Blocks acetylcholinesterase enzyme causing excess accumulation of acetylcholine at the neurojunction and cholinergic poisoning
  • Rx: Decontamination, Atropine, 2-PAM
Tetrodotoxin
  • 100 fresh and salt water varieties (pufferlike fish/blue ringed octopus, frogs)
  • Heat stable, water soluble found in fish skin, liver, ovaries,intestine, and muscle
  • 25 mg (0.000881 oz) expected to be lethal to a 75 kg person
  • Neurotoxicity by inhibition of Na-K pump and blockade neuromuscular transmission
  • Rx: Supportive measures

LD50 expresses the dose at which 50% of exposed population will die as a result of exposure.

Show References

 
Challenges in searching for therapeutics against Botulinum Neurotoxxins. Pirazzini m, rossetto O. Expert Opin Drug Discov. 2017 May;12 (5):497-510.
 
Toxicology of organophosphorous compounds in view of an increasing terrorist threat. Worek F, Willie T, et al. Arch Toxicol. 2016. Sep;90(9):2131-45. doi: 10.1007/s00204-016-1772-1. Epub 2016 Jun 27.
 
The need for empriricaly derived permeation data for personal preotective equipment. Blayney MB. Appl Occup Environ Hyg. 2001 Feb:1692): 233-236.
 
Death by food. Byard RW. Forensic Sci Med Pathol. 2017. Jul 15 doi: 10.1007/s12024-017-9899-9 [Epub ahead of print].
 
 

 

 

 

 



Title: Outcomes of Early Deep Sedation of the Mechanically-Ventilated Patient (Submitted by Andrew Deitchman)

Category: Critical Care

Keywords: Mechanical ventilation, sedation (PubMed Search)

Posted: 8/30/2017 by Kami Windsor, MD

Background: Sedation and analgesia are key components for mechanically ventilated patients. While significant data exists regarding how to manage sedation and analgesia in the ICU setting, very little data exists on management in the ED.

Data: A prospective, single-center, observational study of mechanically-ventilated adult patients used linear regression to identify ED sedation practices and outcomes, with a focus on sedation characteristics using the Richmond Agitation-Sedation Scale (RASS).

Findings:

  • 15% of intubated patients had no sedation or analgesia ordered
  • 64% of intubated patients were documented as deeply-sedated (RASS -3 to -5)
  • Deep sedation was not only associated with more ventilator days, but also increased mortality, with an adjusted OR of 0.77 (95% CI 0.54-0.94) favoring patients with lighter sedation.


Bottom line:  Avoid early deep sedation in your intubated patients as this may be directly associated with increased mortality. Instead, a goal RASS of 0 to -2 should be appropriate for most non-paralyzed, mechanically-ventilated ED patients, extrapoloating from ICU guidelines.

Show References

Stephens, R.J., et al., Analgosedation Practices and the Impact of Sedation Depth on Clinical Outcomes Among Patients Requiring Mechanical Ventilation in the ED: A Cohort Study. Chest, 2017 [Epub ahead of print].

Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, et al.; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41:263–306.

 


Title: Concussion outcome predictors

Category: Orthopedics

Keywords: Concussion recovery (PubMed Search)

Posted: 8/26/2017 by Brian Corwell, MD (Updated: 9/18/2026)

There is tremendous interest in identifying factors that may influence outcome from sports related concussion.

The strongest predictor of slower recovery is the severity of symptoms in the 1-2 days post injury

     -Fewer Sx's in this time period predict a quicker recovery

Pre injury history of mental health problems, depression or migraine headaches predict a longer recovery course

Teenagers might be more vulnerable to having persistent symptoms with greater risk for girls than boys

Having a prior concussion is a risk for having a future concussion

The large majority of injured athletes recover from a clinical perspective within the first month of injury many within the first 10 days

Show References

McCrory P et al. Br J Sports Med 2017;51:838-847.



Title: What about Anaphylaxis in kids? (submitted by Yitschok Applebaum, MD)

Category: Pediatrics

Keywords: allergic reaction, anaphylaxis, auto-injector, epi-pen (PubMed Search)

Posted: 8/25/2017 by Mimi Lu, MD (Updated: 8/25/2017)

What if you were out in public and a 1 year old child (est 10 kg) suddenly develops anaphylaxis but you only have an epinephrine auto-injector with the “adult” dose of 0.3 mg.  Is it safe to give?

Anaphylaxis is a life threatening emergency with mortality of up to 2% [1]. Early recognition is imperative and administration of timely Epinephrine is the single most important intervention [2]. While providers may be hesitant to administer epinephrine in older patients due to fear of precipitating adverse cardiovascular events, they may also hesitate in younger patients due to fear of overdose. 

Iimmediate administration with any dose available is recommended because:

  • the risks of untreated anaphylaxis are greater than the risk of over-treating with epinephrine.
  • 20% of Anaphylaxis patients require a second dose of Epinephrine [3].
  • The recommended IM dose of 0.01mg /kg was determined arbitrarily.
  • The vast majority of epinephrine overdoses are via IV injection at doses 100 - 1000 fold the recommended  IV dose [4]

Bottom line:

There are no absolute contraindications (including age) for epinephrine in patients with anaphylaxis.  Give the initial dose IM into the anterolateral thigh.

Show References

1-  Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001 Jan. 107(1):191-3. [Medline].

2-  Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009; 64:204.

3-  Oren E, Banerji A, Clark S, Camargo CA Jr. Food-induced anaphylaxis and repeated epinephrine treatments. Ann Allergy Asthma Immunol 2007; 99:429.

4-  Wood JP, Traub SJ, Lipinski C. Safety of epinephrine for anaphylaxis in the emergency setting. World Journal of Emergency Medicine. 2013;4(4):245-251. doi:10.5847/wjem.j.issn.1920-8642.2013.04.001.



Title: Idarucizumab for Dabigatran reversal 2.0

Category: Toxicology

Keywords: dabigatran reversal, Idarucizumab (PubMed Search)

Posted: 8/25/2017 by Hong Kim, MD

Full cohort analysis idarucizumab for dabigatran associated bleeding was recently published in NEJM.

This study evaluated the laboratory correction of elevated ecarin clotting time or diluted thrombin time induced by dabigatran and time to either cessation of bleeding (Group A: patients with GI bleeding, traumatic bleeding, or ICH) or time to surgery (Group B: patients requiring surgical intervention within 8 hours).

Findings

Group A (n=301): Median time to the cessation of bleeding was 2.5 hours in 134 patients.

HOWEVER:

  • Bleeding cessation could not be determined in 67 patients
  • Cessation of bleeding could not be assess in 98 patients with ICH
  • Bleeding stopped spontaneously in 2 patients.

Group B (n=202): Median time to intended surgery after infusion of idarucizumab was 1.6 hours.

  • Normal hemostasis in 184 patients (93.4%), mildly abnormal in 10, and moderately abnormal in 3.
  • Many received PRBC and other blood products during surgery

Laboratory markers:

100% reversal of abnormal ecarin clotting time or diluted thrombin time within 4 hours after the administration

Mortality

  • 5 Day: Group A: 6.3% vs. Group B: 12.6%
  • 30 Day: Group A: 13.5% vs. Group B: 12.6%
  • 90 Day: Group A: 18.8% vs. Group B: 18.9%

 

Conclusion

Authors concluded thate idaurcizumab is an "effective" reversal agent for dabigatran.

Overall, the findings are more promising compared to the interim analysis that was published in 2015.

 

Show Additional Information

Other findings:

Infusion of idarucizumab decreased the dabigatran level from 110 ng/mL (Group A) and 73.6 ng/mL (Group B) to < 20 ng/mL.

Rebound levels of > 20 ng/mL were noted in 191 patients after 12 – 24 hours after idarucizumab adminiatration 

Thrombotic events occured in 24 patients (14 in Group A and 10 in Group B) within 30 days after treatment

Serious adverse events occured in 23.3% of the patients within 5 days.

Most frequent events were:

  • Group A: delirum 2.3%
  • Group B: cardiac arrest 3.5%; septic shock 3.0%  

Show References

Pollack CV et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Eng J Med 2017;377:431-41.



Previous  |  1 |  ... |  81 |  82 |  83 |  84 |  85 |  86 |  87 |  88 |  89 |  90 |  91 |  ... |  239 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map